In addition, multiple components of the complement system, a central mediator of RT-induced tumor-specific immunity (22), were upregulated — specifically, C1qa, C1qb, C1ra, C1s1, C3, C3ar1, C4b, and C6. This evidence concerns the gene C3 and neoplasm.